Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER(R)) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps GlobeNewswire November 12, 2025 Company to host conference call and webcast today, November 12, at 8:30 am EST/2:30 pm CET IMA402 and IMA401 TCR Bispecifics showed favorable tolerability at RP2D as […]

Sitryx presents new preclinical data highlighting PKM2 as a promising metabolic target for the treatment of atopic dermatitis at the Inflammatory Disease Skin Summit 2025 GlobeNewswire November 12, 2025 Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis pathology SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights AtaiBeckley solidifies position as a global leader in transformative mental health therapies with a short psychedelic duration GlobeNewswire November 12, 2025 BPL-003 (mebufotenin benzoate nasal spray) granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for treatment-resistant depression (TRD) Reported positive

Bexorg Strengthens Leadership Team with Appointment of Sean Murphy, Ph.D., as Chief Technology Officer Dr. Murphy to lead the continued scale up and expansion of Bexorg's fully integrated AI and whole-human brain platform focused on CNS diseases GlobeNewswire November 12, 2025 NEW HAVEN, Conn., Nov. 12, 2025 (GLOBE NEWSWIRE) — Bexorg, Inc., the first integrated

Energous Wireless Power Solutions Reports Third Quarter 2025 Results GlobeNewswire November 12, 2025 – Reports Revenue of $1.3 Million – Posting third consecutive quarter of growth –– Lowest Quarterly Net Loss in the last Decade – Evidencing further progress toward profitability – SAN JOSE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Energous Corporation d/b/a Energous

Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights GlobeNewswire November 12, 2025 CARVYKTI(R) (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $524 million EC and U.S. FDA label updates for CARVYKTI(R) to include overall survival benefit versus standard of care Over 9,000 patients treated to date Initiated CARVYKTI(R) commercial production at Tech Lane

According to MarketsandMarkets™, the global Medium Frequency Magnetics Market is anticipated to grow from estimated USD 1.99 billion in 2025 to USD 2.70 billion by 2030, at a CAGR of 6.3% during the forecast period. A key driver for the Medium Frequency Magnetics Market is the growing demand for efficient power conversion and energy management

(TSX:ASCU),(OTC US:ASCUF),(Other OTC:ASCUF), NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CASA GRANDE, Ariz. and TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU” or the “Company”) is pleased to announce that it has entered into an agreement with Canaccord Genuity

Arizona Sonoran Announces C$75 Million “Bought Deal” Private Placement of Common Shares GlobeNewswire November 12, 2025 NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CASA GRANDE, Ariz. and TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU” or the “Company”) is

Yachting: G-Spot Sets the Pace as Monaco Sportsboat Winter Series Opens GlobeNewswire November 12, 2025 MONACO, Nov. 12, 2025 (GLOBE NEWSWIRE) — The 2025-2026 Monaco Sportsboat Winter Series kicked off under the steady hand of the Yacht Club de Monaco, marking the start of a new competitive season with Act I. Over four days, 23